250 related articles for article (PubMed ID: 24368769)
1. Ubiquitination regulates expression of the serine/arginine-rich splicing factor 1 (SRSF1) in normal and systemic lupus erythematosus (SLE) T cells.
Moulton VR; Gillooly AR; Tsokos GC
J Biol Chem; 2014 Feb; 289(7):4126-34. PubMed ID: 24368769
[TBL] [Abstract][Full Text] [Related]
2. Serine Arginine-Rich Splicing Factor 1 (SRSF1) Contributes to the Transcriptional Activation of CD3ζ in Human T Cells.
Moulton VR; Gillooly AR; Perl MA; Markopoulou A; Tsokos GC
PLoS One; 2015; 10(7):e0131073. PubMed ID: 26134847
[TBL] [Abstract][Full Text] [Related]
3. Decreased Expression of Serine/Arginine-Rich Splicing Factor 1 in T Cells From Patients With Active Systemic Lupus Erythematosus Accounts for Reduced Expression of RasGRP1 and DNA Methyltransferase 1.
Kono M; Kurita T; Yasuda S; Kono M; Fujieda Y; Bohgaki T; Katsuyama T; Tsokos GC; Moulton VR; Atsumi T
Arthritis Rheumatol; 2018 Dec; 70(12):2046-2056. PubMed ID: 29905030
[TBL] [Abstract][Full Text] [Related]
4. Estrogen-Induced hsa-miR-10b-5p Is Elevated in T Cells From Patients With Systemic Lupus Erythematosus and Down-Regulates Serine/Arginine-Rich Splicing Factor 1.
Ramanujan SA; Cravens EN; Krishfield SM; Kyttaris VC; Moulton VR
Arthritis Rheumatol; 2021 Nov; 73(11):2052-2058. PubMed ID: 33982889
[TBL] [Abstract][Full Text] [Related]
5. Splicing factor SF2/ASF rescues IL-2 production in T cells from systemic lupus erythematosus patients by activating IL-2 transcription.
Moulton VR; Grammatikos AP; Fitzgerald LM; Tsokos GC
Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1845-50. PubMed ID: 23319613
[TBL] [Abstract][Full Text] [Related]
6. Alternative splicing factor/splicing factor 2 regulates the expression of the zeta subunit of the human T cell receptor-associated CD3 complex.
Moulton VR; Tsokos GC
J Biol Chem; 2010 Apr; 285(17):12490-6. PubMed ID: 20118245
[TBL] [Abstract][Full Text] [Related]
7. Splicing factor SRSF1 controls T cell homeostasis and its decreased levels are linked to lymphopenia in systemic lupus erythematosus.
Katsuyama T; Martin-Delgado IJ; Krishfield SM; Kyttaris VC; Moulton VR
Rheumatology (Oxford); 2020 Aug; 59(8):2146-2155. PubMed ID: 32206811
[TBL] [Abstract][Full Text] [Related]
8. Splicing factor SRSF1 controls T cell hyperactivity and systemic autoimmunity.
Katsuyama T; Li H; Comte D; Tsokos GC; Moulton VR
J Clin Invest; 2019 Dec; 129(12):5411-5423. PubMed ID: 31487268
[TBL] [Abstract][Full Text] [Related]
9. Splicing factor SRSF1 controls distinct molecular programs in regulatory and effector T cells implicated in systemic autoimmune disease.
Cassidy MF; Herbert ZT; Moulton VR
Mol Immunol; 2022 Jan; 141():94-103. PubMed ID: 34839165
[TBL] [Abstract][Full Text] [Related]
10. Splicing factor SRSF1 controls autoimmune-related molecular pathways in regulatory T cells distinct from FoxP3.
Cassidy MF; Herbert ZT; Moulton VR
Mol Immunol; 2022 Dec; 152():140-152. PubMed ID: 36368121
[TBL] [Abstract][Full Text] [Related]
11. Inhibited expression of hematopoietic progenitor kinase 1 associated with loss of jumonji domain containing 3 promoter binding contributes to autoimmunity in systemic lupus erythematosus.
Zhang Q; Long H; Liao J; Zhao M; Liang G; Wu X; Zhang P; Ding S; Luo S; Lu Q
J Autoimmun; 2011 Nov; 37(3):180-9. PubMed ID: 22014533
[TBL] [Abstract][Full Text] [Related]
12. A novel intronic cAMP response element modulator (CREM) promoter is regulated by activator protein-1 (AP-1) and accounts for altered activation-induced CREM expression in T cells from patients with systemic lupus erythematosus.
Rauen T; Benedyk K; Juang YT; Kerkhoff C; Kyttaris VC; Roth J; Tsokos GC; Tenbrock K
J Biol Chem; 2011 Sep; 286(37):32366-72. PubMed ID: 21757709
[TBL] [Abstract][Full Text] [Related]
13. Excessive production of IFN-gamma in patients with systemic lupus erythematosus and its contribution to induction of B lymphocyte stimulator/B cell-activating factor/TNF ligand superfamily-13B.
Harigai M; Kawamoto M; Hara M; Kubota T; Kamatani N; Miyasaka N
J Immunol; 2008 Aug; 181(3):2211-9. PubMed ID: 18641361
[TBL] [Abstract][Full Text] [Related]
14. mRNA expression analysis confirms CD44 splicing impairment in systemic lupus erythematosus patients.
Latini A; Novelli L; Ceccarelli F; Barbati C; Perricone C; De Benedittis G; Conti F; Novelli G; Ciccacci C; Borgiani P
Lupus; 2021 Jun; 30(7):1086-1093. PubMed ID: 33794704
[TBL] [Abstract][Full Text] [Related]
15. Correlation of SRSF1 and PRMT1 expression with clinical status of pediatric acute lymphoblastic leukemia.
Zou L; Zhang H; Du C; Liu X; Zhu S; Zhang W; Li Z; Gao C; Zhao X; Mei M; Bao S; Zheng H
J Hematol Oncol; 2012 Jul; 5():42. PubMed ID: 22839530
[TBL] [Abstract][Full Text] [Related]
16. Emerging functions of SRSF1, splicing factor and oncoprotein, in RNA metabolism and cancer.
Das S; Krainer AR
Mol Cancer Res; 2014 Sep; 12(9):1195-204. PubMed ID: 24807918
[TBL] [Abstract][Full Text] [Related]
17. T cell activation regulates CD6 alternative splicing by transcription dynamics and SRSF1.
da Glória VG; Martins de Araújo M; Mafalda Santos A; Leal R; de Almeida SF; Carmo AM; Moreira A
J Immunol; 2014 Jul; 193(1):391-9. PubMed ID: 24890719
[TBL] [Abstract][Full Text] [Related]
18. Abnormal CTLA-4 function in T cells from patients with systemic lupus erythematosus.
Jury EC; Flores-Borja F; Kalsi HS; Lazarus M; Isenberg DA; Mauri C; Ehrenstein MR
Eur J Immunol; 2010 Feb; 40(2):569-78. PubMed ID: 19950182
[TBL] [Abstract][Full Text] [Related]
19. Splicing factor SRSF1 limits IFN-γ production via RhoH and ameliorates experimental nephritis.
Katsuyama T; Li H; Krishfield SM; Kyttaris VC; Moulton VR
Rheumatology (Oxford); 2021 Jan; 60(1):420-429. PubMed ID: 32810232
[TBL] [Abstract][Full Text] [Related]
20. A splice variant of the TCR zeta mRNA lacking exon 7 leads to the down-regulation of TCR zeta, the TCR/CD3 complex, and IL-2 production in systemic lupus erythematosus T cells.
Tsuzaka K; Setoyama Y; Yoshimoto K; Shiraishi K; Suzuki K; Abe T; Takeuchi T
J Immunol; 2005 Mar; 174(6):3518-25. PubMed ID: 15749888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
